share_log

CBD Global Sciences Begins The Process Of Name Change In Keeping With 'Ever-Changing Industry'

CBD Global Sciences Begins The Process Of Name Change In Keeping With 'Ever-Changing Industry'

CBD Global Sciences啟動更名進程,以適應不斷變化的行業
Benzinga Real-time News ·  2022/03/15 23:20

CBD Global Sciences, Inc. (OTC:CBDNF) (CSE:CBDN) (Frankfurt:GS3) has begun the process to formally change its name from "CBD Global Sciences" to "Global Sciences Inc.," dropping CBD from its name.

CBD全球科學公司(場外交易代碼:CBDNF)(CSE:CBDN)(法蘭克福:GS3)已經開始正式將其名稱從“CBD Global Sciences”更名為“Global Science Inc.”,將CBD從其名稱中刪除。

It will operate under the trade name "Global Sciences" until full shareholder and regulatory approval of the new name is received. This move comes with the opportunity to expand the company's focus to more than just CBD with recently discovered opportunities that it says will create value for its shareholders.

該公司將以“Global Sciences”的商標運營,直到獲得新名稱的正式股東和監管機構的批准。這一舉措伴隨着將公司的重點擴大到不僅僅是CBD的機會,最近發現的機會,它説將為其股東創造價值。

The name change will not impact the company's ability to increase revenues and profitability within the CBD and distribution industries, but rather will enhance its ability to better define itself as it explores other areas in the field of wellness sciences. When approved, the company's trading symbol will change accordingly.

更名不會影響該公司在CBD和分銷行業增加收入和盈利的能力,但會增強其在探索健康科學領域的其他領域時更好地定義自己的能力。一旦獲得批准,該公司的交易代碼將相應更改。

Brad Wyatt, CEO of CBD Global Sciences stated, "In the ever-changing industry of CBD the team at Global Sciences has become accustomed to quickly pivoting to provide better value to its customers and shareholders. This change is the beginning of more exciting news that will be presented in the near term. We are still very active in the CBD landscape and presenting wins for our company with lower cost manufacturing and more points of distribution which will translate into increased revenues and improved profitability. We are very excited about 2022 and beyond for our company and its shareholders."

布拉德·懷亞特在不斷變化的CBD行業中,Global Sciences的團隊已經習慣於快速轉向,為其客户和股東提供更好的價值。這一變化是近期將呈現的更令人興奮的消息的開始。我們仍然非常活躍在CBD領域,以更低的製造成本和更多的分銷點為我們的公司帶來勝利,這將轉化為收入的增加和盈利的改善。我們對2022年及以後為我們的公司及其股東感到非常興奮。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論